Recent News

Before you get a flu shot, get good sleep to increase its effectiveness, experts say

Oct 23 2020

(CNN)We all know how much better we feel after a good night's sleep. It turns out that sleep may be vital to arm us in the fight against influenza and Covid-19. Medical professionals are recommending that people make sure to get their flu shots this year, in part because some Covid-19 and flu symptoms are similar. A flu shot reduces the likelihood that your symptoms (if you get sick) are from the flu. To make that flu shot effective, sleep specialist Matthew Walker, the bestselling author of "Why We Sleep," told CNN's Christiane Amanpour practicing "good sleep hygiene" is important.

Source: CNN

Why decoding the immune response to COVID matters for vaccines

Oct 23 2020

The race is on to develop a vaccine to protect people against the new coronavirus, SARS-CoV-2. Less than a year after the virus was identified, almost 200 vaccines are in development and more than 40 are in clinical trials — thanks, in part, to an unprecedented collaborative effort by researchers around the world. The vaccine quest makes it necessary for researchers to answer questions about how the body’s immune system responds to the virus, and why some people experience severe symptoms, whereas others recover quickly.

Source: Nature

How Colorado Plans To Distribute A COVID-19 Vaccine

Oct 23 2020

The idea of a COVID-19 vaccine raises some interesting practical and ethical questions about who should get one first, especially if limited supplies may be available. States were required to submit a plan for how they would distribute a vaccine to the Centers for Disease Control and Prevention by the weekend. Dr. Eric France, chief medical officer for the Colorado Department of Public Health and Environment, joined KUNC’s Colorado Edition to explain what is included in our state’s plan.

Source: KUNC

Overcoming Covid-19 Vaccine Hesitancy: Lessons From Elvis

Oct 22 2020

For months now multiple companies have been feverishly working to complete huge studies with their Covid-19 vaccines as governments around the world are desperate to protect their citizens and get their respective economies open again. These studies are going well enough that it is entirely likely that one or more vaccines will be available by early next year. But beyond proving the safety and efficacy of their vaccines, there is a different – and bigger – problem.

Source: Forbes

FDA opens private Covid vaccine meetings to the public in bid to gain trust as Trump pressures for fast approval

Oct 22 2020

The FDA took the unusual step Thursday in opening to the public a routine meeting with an advisory group that’s weighing in on approving the coronavirus vaccine as the agency battles public concerns about its safety as well as political pressure from President Donald Trump to approve it before the Nov. 3 election. The Vaccines and Related Biological Products Advisory Committee, an outside group of researchers and physicians who are advising the Food and Drug Administration on whether to approve a Covid-19 vaccine, debated the standards needed to ensure a Covid-19 vaccine is safe and effective in a meeting broadcast on YouTube and C-SPAN. Those are key questions among medical experts who worry the U.S. will approve a vaccine before it has been adequately tested.

Source: CNBC

Moderna’s coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities

Oct 22 2020

Moderna, the biotechnology firm partnering with the National Institutes of Health to develop a coronavirus vaccine, announced Thursday that it has fully enrolled its trial, with 30,000 participants — more than a third of whom are minorities. The coronavirus vaccine trials have been closely watched to ensure they reflect the diversity of the U.S. population at a minimum, and Moderna’s enrollment was slowed in September to recruit more minorities. A fifth of the participants are Hispanic and 10 percent are Black, according to data released by the company. People over 65, a population also at high risk for coronavirus, make up 25 percent of the study population.

Source: WP

Next up in hunt for Covid-19 vaccine: Testing shots in kids

Oct 22 2020

The global hunt for a Covid-19 vaccine for kids is only just beginning — a lagging start that has some U.S. pediatricians worried they may not know if any shots work for young children in time for the next school year. Older adults may be most vulnerable to the coronavirus, but ending the pandemic will require vaccinating children, too. Last week, Pfizer Inc. received permission to test its vaccine in U.S. kids as young as 12, one of only a handful of attempts around the world to start exploring if any experimental shots being pushed for adults also can protect children.

Source: NBC

Maternal vaccination rates remain subpar in US women, racial disparities persist

Oct 22 2020

In the latest Morbidity and Mortality Weekly Report (MMWR) published by the US Centers for Disease Control and Prevention (CDC) in early October, vaccination coverage in pregnant women was assessed for two key vaccines: influenza (flu) and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap). Both vaccines protect the mother and child from potentially high-risk complications. However, findings suggest that just over half of pregnant women in the US receive these vaccines, with disproportionately lower maternal vaccination rates among Black and Hispanic women.

Source: .pharmaceutical-technolog

What if the Covid-19 vaccine only works half the time?

Oct 22 2020

In the not-so-distant future — we’ll probably know who won the 2020 election, but memories of the weirdest Thanksgiving ever will not have faded — you may be faced with an incredibly important choice. Should you get the Covid-19 vaccine? It’s been less than a year since the discovery of SARS-CoV-2, the virus that causes the new disease, and we have not just one, but multiple vaccine candidates that may in time truly shut the door on the pandemic.

Source: Vox